{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:21:31Z","timestamp":1762928491336},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,4,4]],"date-time":"2017-04-04T00:00:00Z","timestamp":1491264000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00430-017-0492-3","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T07:21:27Z","timestamp":1491376887000},"page":"195-201","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Role of IL-21 in HTLV-1 infections with emphasis on HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)"],"prefix":"10.1007","volume":"206","author":[{"given":"Taraneh","family":"Rajaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Farajifard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houshang","family":"Rafatpanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Bustani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narges","family":"Valizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahareh","family":"Rajaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Abdolrahim","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,4]]},"reference":[{"key":"492_CR1","doi-asserted-by":"publisher","first-page":"15012","DOI":"10.1038\/nrdp.2015.12","volume":"1","author":"CRM Bangham","year":"2015","unstructured":"Bangham CRM, Araujo A, Yamano Y, Taylor GP (2015) HTLV-1-associated myelopathy\/tropical spastic paraparesis. Nat Rev Dis Prim 1:15012. doi:\n10.1038\/nrdp.2015.12","journal-title":"Nat Rev Dis Prim"},{"key":"492_CR2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jcv.2011.07.004","volume":"52","author":"H Rafatpanah","year":"2011","unstructured":"Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F et al (2011) High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol 52:172\u2013176. doi:\n10.1016\/j.jcv.2011.07.004","journal-title":"J Clin Virol"},{"key":"492_CR3","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s13311-015-0369-3","volume":"12","author":"R Boostani","year":"2015","unstructured":"Boostani R, Vakili R, Hosseiny SS et al (2015) Triple therapy with prednisolone, pegylated interferon and sodium valproate improves clinical outcome and reduces human T-cell leukemia virus type 1 (HTLV-1) proviral load, tax and HBZ mRNA expression in patients with HTLV-1-associated myelopathy\/tropical. Neurother 12:887\u2013895. doi:\n10.1007\/s13311-015-0369-3","journal-title":"Neurother"},{"key":"492_CR4","first-page":"531","volume":"17","author":"A Yari","year":"2014","unstructured":"Yari A, Rezaee SA, Valizadeh N et al (2014) Evaluation of HTLV-1 activity in HAM\/TSP patients using proviral load and Tax mRNA expression after In Vitro lymphocyte activation. Iran J BasicMed Sci 17:531\u2013536","journal-title":"Iran J BasicMed Sci"},{"key":"492_CR5","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1182\/blood-2008-06-163071","volume":"112","author":"CR Bangham","year":"2008","unstructured":"Bangham CR (2008) HTLV-1 infection: role of CTL efficiency. Blood 112:2176\u20132177. doi:\n10.1182\/blood-2008-06-163071","journal-title":"Blood"},{"key":"492_CR6","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1182\/blood-2007-10-118539","volume":"111","author":"F Toulza","year":"2008","unstructured":"Toulza F, Heaps A, Tanaka Y et al (2008) High frequency of CD4\u00a0+\u00a0FoxP3\u00a0+\u00a0cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response. Blood 111:5047\u20135053. doi:\n10.1182\/blood-2007-10-118539","journal-title":"Blood"},{"key":"492_CR7","doi-asserted-by":"publisher","unstructured":"Massoud R, Enose-akahata Y, Tagaya Y, et al (2015) Common \u03b3-chain blocking peptide reduces in vitro immune activation markers in HTLV-1-associated myelopathy\/tropical spastic paraparesis. 112:2\u20137. doi:\n10.1073\/pnas.1412626112","DOI":"10.1073\/pnas.1412626112"},{"key":"492_CR8","doi-asserted-by":"publisher","unstructured":"Levin MC, Lee SM, Kalume F, et al (2009) Neurological disease. 8:509\u2013513. doi:\n10.1038\/nm0502-509\n\n. Autoimmunity","DOI":"10.1038\/nm0502-509"},{"key":"492_CR9","unstructured":"Tamayo O (2005) Autoimmunity and molecular mimicry in tropical spastic paraparesis\/human myelopathy. 38:241\u2013250"},{"key":"492_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.4049\/jimmunol.0901967","volume":"184","author":"A Iannello","year":"2010","unstructured":"Iannello A, Boulassel MR, Samarani S et al (2010) Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study. J Immunol 184:114\u2013126. doi:\n10.4049\/jimmunol.0901967","journal-title":"J Immunol"},{"key":"492_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cytogfr.2007.04.003","volume":"18","author":"K Brandt","year":"2007","unstructured":"Brandt K, Singh PB, Bulfone-Paus S, Ruckert R (2007) Interleukin-21: a new modulator of immunity, infection, and cancer. Cytokine Growth Factor Rev 18:223\u2013232. doi:\n10.1016\/j.cytogfr.2007.04.003","journal-title":"Cytokine Growth Factor Rev"},{"key":"492_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.immunol.26.021607.090316","volume":"26","author":"R Spolski","year":"2008","unstructured":"Spolski R, Leonard WJ (2008) Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol 26:57\u201379. doi:\n10.1146\/annurev.immunol.26.021607.090316","journal-title":"Annu Rev Immunol"},{"key":"492_CR13","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1172\/JCI44198","volume":"121","author":"J Publicover","year":"2011","unstructured":"Publicover J, Goodsell A, Nishimura S et al (2011) IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. J Clin Invest 121:1154\u20131162. doi:\n10.1172\/JCI44198","journal-title":"J Clin Invest"},{"key":"492_CR14","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1126\/science.1175194","volume":"324","author":"JS Yi","year":"2009","unstructured":"Yi JS, Du M, Zajac AJ (2009) A vital role for interleukin-21 in the control of a chronic viral infection. Science 324:1572\u20131576. doi:\n10.1126\/science.1175194","journal-title":"Science"},{"key":"492_CR15","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1084\/jem.20081398","volume":"205","author":"RB Jones","year":"2008","unstructured":"Jones RB, Ndhlovu LC, Barbour JD et al (2008) Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 205:2763\u20132779. doi:\n10.1084\/jem.20081398","journal-title":"J Exp Med"},{"key":"492_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature05115","volume":"443","author":"CL Day","year":"2006","unstructured":"Day CL, Kaufmann DE, Kiepiela P et al (2006) PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443:350\u2013354. doi:\n10.1038\/nature05115","journal-title":"Nature"},{"key":"492_CR17","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1084\/jem.20061496","volume":"203","author":"C Petrovas","year":"2006","unstructured":"Petrovas C, Casazza JP, Brenchley JM et al (2006) PD-1 is a regulator of virus-specific CD8\u00a0+\u00a0T cell survival in HIV infection. J Exp Med 203:2281\u20132292. doi:\n10.1084\/jem.20061496","journal-title":"J Exp Med"},{"key":"492_CR18","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/nm1482","volume":"12","author":"L Trautmann","year":"2006","unstructured":"Trautmann L, Janbazian L, Chomont N et al (2006) Upregulation of PD-1 expression on HIV-specific CD8 + T cells leads to reversible immune dysfunction. Nat Med 12:1198\u20131202. doi:\n10.1038\/nm1482","journal-title":"Nat Med"},{"key":"492_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ni.1679","volume":"10","author":"SD Blackburn","year":"2009","unstructured":"Blackburn SD, Shin H, Haining WN et al (2009) Coregulation of CD8\u00a0+\u00a0T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 10:29\u201337. doi:\n10.1038\/ni.1679","journal-title":"Nat Immunol"},{"key":"492_CR20","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1126\/science.1172815","volume":"324","author":"A Frohlich","year":"2009","unstructured":"Frohlich A, Kisielow J, Schmitz I, et al (2009) IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 324:1576\u20131580. doi:\n10.1126\/science.1172815","journal-title":"Science"},{"key":"492_CR21","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1126\/science.1174182","volume":"324","author":"H Elsaesser","year":"2009","unstructured":"Elsaesser H, Sauer K, Brooks DG (2009) IL-21 is required to control chronic viral infection. Science 324:1569\u20131572. doi:\n10.1126\/science.1174182","journal-title":"Science"},{"key":"492_CR22","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1128\/JVI.02030-10","volume":"85","author":"MF Chevalier","year":"2011","unstructured":"Chevalier MF, Julg B, Pyo A et al (2011) HIV-1-specific interleukin-21 + CD4 + T cell responses contribute to durable viral control through the modulation of HIV-specific CD8 + T cell function. J Virol 85:733\u2013741. doi:\n10.1128\/JVI.02030-10","journal-title":"J Virol"},{"key":"492_CR23","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4049\/jimmunol.0903915","volume":"185","author":"FY Yue","year":"2010","unstructured":"Yue FY, Lo C, Sakhdari A et al (2010) HIV-specific IL-21 producing CD4 + T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control. J Immunol 185:498\u2013506. doi:\n10.4049\/jimmunol.0903915","journal-title":"J Immunol"},{"key":"492_CR24","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1189\/jlb.1009701","volume":"87","author":"A Iannello","year":"2010","unstructured":"Iannello A, Boulassel MR, Samarani S et al (2010) IL-21 enhances NK cell functions and survival in healthy and HIV-infected patients with minimal stimulation of viral replication. J Leukoc Biol 87:857\u2013867. doi:\n10.1189\/jlb.1009701","journal-title":"J Leukoc Biol"},{"key":"492_CR25","doi-asserted-by":"publisher","first-page":"732","DOI":"10.4049\/jimmunol.178.2.732","volume":"178","author":"I Peluso","year":"2007","unstructured":"Peluso I, Fantini MC, Fina D et al (2007) IL-21 Counteracts the Regulatory T Cell-Mediated Suppression of Human CD4+ T Lymphocytes. J Immunol 178:732\u2013739. doi:\n10.4049\/jimmunol.178.2.732","journal-title":"J Immunol"},{"key":"492_CR26","doi-asserted-by":"publisher","first-page":"25501","DOI":"10.1074\/jbc.M109.010959","volume":"284","author":"M Mizuguchi","year":"2009","unstructured":"Mizuguchi M, Asao H, Hara T et al (2009) Transcriptional activation of the interleukin-21 gene and its receptor gene by human T-cell leukemia virus type 1 Tax in human T-cells. J Biol Chem 284:25501\u201325511. doi:\n10.1074\/jbc.M109.010959","journal-title":"J Biol Chem"},{"key":"492_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2141.2004.05255.x","volume":"128","author":"M Ueda","year":"2005","unstructured":"Ueda M, Imada K, Imura A et al (2005) Expression of functional interleukin-21 receptor on adult T-cell leukaemia cells. Br J Haematol 128:169\u2013176. doi:\n10.1111\/j.1365-2141.2004.05255.x","journal-title":"Br J Haematol"},{"key":"492_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneuroim.2012.05.004","volume":"250","author":"H Rafatpanah","year":"2012","unstructured":"Rafatpanah H, Rezaee A, Etemadi MM et al (2012) The impact of interferon-alpha treatment on clinical and immunovirological aspects of HTLV-1-associated myelopathy in northeast of Iran. J Neuroimmunol 250:87\u201393. doi:\n10.1016\/j.jneuroim.2012.05.004","journal-title":"J Neuroimmunol"},{"key":"492_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1742-4690-10-51","volume":"10","author":"M Saito","year":"2013","unstructured":"Saito M, Tanaka R, Arishima S et al (2013) Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis. Retrovirology 10:51. doi:\n10.1186\/1742-4690-10-51","journal-title":"Retrovirology"},{"key":"492_CR30","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1093\/infdis\/jiq153","volume":"203","author":"NH Abdelbary","year":"2011","unstructured":"Abdelbary NH, Abdullah HM, Matsuzaki T et al (2011) Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection. J Infect Dis 203:948\u2013959. doi:\n10.1093\/infdis\/jiq153","journal-title":"J Infect Dis"},{"key":"492_CR31","doi-asserted-by":"publisher","first-page":"8560","DOI":"10.1128\/JVI.76.17.8560-8571.2002","volume":"76","author":"DN Everly Jr","year":"2002","unstructured":"Everly DN Jr, Feng P, Mian IS, Read GS (2002) mRNA degradation by the virion host shutoff (Vhs) protein of herpes simplex virus: genetic and biochemical evidence that Vhs is a nuclease. J Virol 76:8560\u20138571","journal-title":"J Virol"},{"key":"492_CR32","first-page":"269","volume":"45","author":"J Matis","year":"2001","unstructured":"Matis J, Kudelova M (2001) Early shutoff of host protein synthesis in cells infected with herpes simplex viruses. Acta Virol 45:269\u2013277","journal-title":"Acta Virol"},{"key":"492_CR33","doi-asserted-by":"publisher","unstructured":"Matsuura E, Kubota R, Tanaka Y (2015) Visualization of HTLV-1 Y specific cytotoxic T lymphocytes in the spinal cords of patients with HTLV-1 Y associated myelopathy\/tropical spastic paraparesis. 74:2\u201314","DOI":"10.1097\/NEN.0000000000000141"},{"key":"492_CR34","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.4049\/jimmunol.167.9.5429","volume":"167","author":"MC Marcondes","year":"2001","unstructured":"Marcondes MC, Burudi EM, Huitron-Resendiz S et al (2001) Highly activated CD8(+) T cells in the brain correlate with early central nervous system dysfunction in simian immunodeficiency virus infection. J Immunol 167:5429\u20135438","journal-title":"J Immunol"},{"key":"492_CR35","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1172\/JCI46187","volume":"121","author":"SM Liu","year":"2011","unstructured":"Liu SM, Lee DH, Sullivan JM et al (2011) Differential IL-21 signaling in APCs leads to disparate Th17 differentiation in diabetes-susceptible NOD and diabetes-resistant NOD. Idd3 mice. J Clin Invest 121:4303\u20134310. doi:\n10.1172\/JCI46187","journal-title":"J Clin Invest"},{"key":"492_CR36","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.4049\/jimmunol.1301454","volume":"191","author":"SM Liu","year":"2013","unstructured":"Liu SM, King C (2013) IL-21-producing Th cells in immunity and autoimmunity. J Immunol 191:3501\u20133506. doi:\n10.4049\/jimmunol.1301454","journal-title":"J Immunol"},{"key":"492_CR37","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1073\/pnas.0807309106","volume":"106","author":"JA Bubier","year":"2009","unstructured":"Bubier JA, Sproule TJ, Foreman O et al (2009) A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice. Proc Natl Acad Sci U S A 106:1518\u20131523. doi:\n10.1073\/pnas.0807309106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"492_CR38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0092-8674(04)00340-X","volume":"117","author":"AM Gallegos","year":"2004","unstructured":"Gallegos AM, Bevan MJ (2004) Driven to autoimmunity: the nod mouse. Cell 117:149\u2013151","journal-title":"Cell"},{"key":"492_CR39","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1053\/j.gastro.2004.12.042","volume":"128","author":"G Monteleone","year":"2005","unstructured":"Monteleone G, Monteleone I, Fina D et al (2005) Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn\u2019s disease. Gastroenterology 128:687\u2013694","journal-title":"Gastroenterology"},{"key":"492_CR40","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1053\/j.gastro.2008.01.041","volume":"134","author":"D Fina","year":"2008","unstructured":"Fina D, Sarra M, Fantini MC et al (2008) Regulation of gut inflammation and th17 cell response by interleukin-21. Gastroenterology 134:1038\u20131048. doi:\n10.1053\/j.gastro.2008.01.041","journal-title":"Gastroenterology"},{"key":"492_CR41","doi-asserted-by":"publisher","first-page":"14028","DOI":"10.1073\/pnas.0804358105","volume":"105","author":"R Spolski","year":"2008","unstructured":"Spolski R, Kashyap M, Robinson C et al (2008) IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proc Natl Acad Sci U S A 105:14028\u201314033. doi:\n10.1073\/pnas.0804358105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"492_CR42","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.4049\/jimmunol.178.6.3822","volume":"178","author":"D Herber","year":"2007","unstructured":"Herber D, Brown TP, Liang S et al (2007) IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J Immunol 178:3822\u20133830","journal-title":"J Immunol"},{"key":"492_CR43","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/art.22452","volume":"56","author":"DA Young","year":"2007","unstructured":"Young DA, Hegen M, Ma HL et al (2007) Blockade of the interleukin-21\/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum 56:1152\u20131163. doi:\n10.1002\/art.22452","journal-title":"Arthritis Rheum"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-017-0492-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-017-0492-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-017-0492-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T04:07:43Z","timestamp":1493352463000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-017-0492-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,4]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["492"],"URL":"https:\/\/doi.org\/10.1007\/s00430-017-0492-3","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,4]]}}}